Global Pazopanib Market Growth 2022-2028
- LP 4768487
- 79 Pages
- January 2022
- Pharmaceuticals
The United States Pazopanib market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Pazopanib market, reaching US$ million by the year 2028. As for the Europe Pazopanib landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Pazopanib players cover Novartis, GlaxoSmithKline, , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Pazopanib market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
200mg Tables
400mg Tables
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Renal Cell Carcinoma
Soft Tissue Sarcoma
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Novartis
GlaxoSmithKline
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pazopanib Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Pazopanib by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Pazopanib by Country/Region, 2017, 2022 & 2028
2.2 Pazopanib Segment by Type
2.2.1 200mg Tables
2.2.2 400mg Tables
2.3 Pazopanib Sales by Type
2.3.1 Global Pazopanib Sales Market Share by Type (2017-2022)
2.3.2 Global Pazopanib Revenue and Market Share by Type (2017-2022)
2.3.3 Global Pazopanib Sale Price by Type (2017-2022)
2.4 Pazopanib Segment by Application
2.4.1 Renal Cell Carcinoma
2.4.2 Soft Tissue Sarcoma
2.4.3 Other
2.5 Pazopanib Sales by Application
2.5.1 Global Pazopanib Sale Market Share by Application (2017-2022)
2.5.2 Global Pazopanib Revenue and Market Share by Application (2017-2022)
2.5.3 Global Pazopanib Sale Price by Application (2017-2022)
3 Global Pazopanib by Company
3.1 Global Pazopanib Breakdown Data by Company
3.1.1 Global Pazopanib Annual Sales by Company (2020-2022)
3.1.2 Global Pazopanib Sales Market Share by Company (2020-2022)
3.2 Global Pazopanib Annual Revenue by Company (2020-2022)
3.2.1 Global Pazopanib Revenue by Company (2020-2022)
3.2.2 Global Pazopanib Revenue Market Share by Company (2020-2022)
3.3 Global Pazopanib Sale Price by Company
3.4 Key Manufacturers Pazopanib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pazopanib Product Location Distribution
3.4.2 Players Pazopanib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Pazopanib by Geographic Region
4.1 World Historic Pazopanib Market Size by Geographic Region (2017-2022)
4.1.1 Global Pazopanib Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Pazopanib Annual Revenue by Geographic Region
4.2 World Historic Pazopanib Market Size by Country/Region (2017-2022)
4.2.1 Global Pazopanib Annual Sales by Country/Region (2017-2022)
4.2.2 Global Pazopanib Annual Revenue by Country/Region
4.3 Americas Pazopanib Sales Growth
4.4 APAC Pazopanib Sales Growth
4.5 Europe Pazopanib Sales Growth
4.6 Middle East & Africa Pazopanib Sales Growth
5 Americas
5.1 Americas Pazopanib Sales by Country
5.1.1 Americas Pazopanib Sales by Country (2017-2022)
5.1.2 Americas Pazopanib Revenue by Country (2017-2022)
5.2 Americas Pazopanib Sales by Type
5.3 Americas Pazopanib Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pazopanib Sales by Region
6.1.1 APAC Pazopanib Sales by Region (2017-2022)
6.1.2 APAC Pazopanib Revenue by Region (2017-2022)
6.2 APAC Pazopanib Sales by Type
6.3 APAC Pazopanib Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pazopanib by Country
7.1.1 Europe Pazopanib Sales by Country (2017-2022)
7.1.2 Europe Pazopanib Revenue by Country (2017-2022)
7.2 Europe Pazopanib Sales by Type
7.3 Europe Pazopanib Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pazopanib by Country
8.1.1 Middle East & Africa Pazopanib Sales by Country (2017-2022)
8.1.2 Middle East & Africa Pazopanib Revenue by Country (2017-2022)
8.2 Middle East & Africa Pazopanib Sales by Type
8.3 Middle East & Africa Pazopanib Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pazopanib
10.3 Manufacturing Process Analysis of Pazopanib
10.4 Industry Chain Structure of Pazopanib
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pazopanib Distributors
11.3 Pazopanib Customer
12 World Forecast Review for Pazopanib by Geographic Region
12.1 Global Pazopanib Market Size Forecast by Region
12.1.1 Global Pazopanib Forecast by Region (2023-2028)
12.1.2 Global Pazopanib Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pazopanib Forecast by Type
12.7 Global Pazopanib Forecast by Application
13 Key Players Analysis
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Pazopanib Product Offered
13.1.3 Novartis Pazopanib Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
14 Research Findings and Conclusion
Table 1. Pazopanib Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Pazopanib Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 200mg Tables
Table 4. Major Players of 400mg Tables
Table 5. Global Pazopanib Sales by Type (2017-2022) & (K Pcs)
Table 6. Global Pazopanib Sales Market Share by Type (2017-2022)
Table 7. Global Pazopanib Revenue by Type (2017-2022) & ($ million)
Table 8. Global Pazopanib Revenue Market Share by Type (2017-2022)
Table 9. Global Pazopanib Sale Price by Type (2017-2022) & (USD/Pcs)
Table 10. Global Pazopanib Sales by Application (2017-2022) & (K Pcs)
Table 11. Global Pazopanib Sales Market Share by Application (2017-2022)
Table 12. Global Pazopanib Revenue by Application (2017-2022)
Table 13. Global Pazopanib Revenue Market Share by Application (2017-2022)
Table 14. Global Pazopanib Sale Price by Application (2017-2022) & (USD/Pcs)
Table 15. Global Pazopanib Sales by Company (2020-2022) & (K Pcs)
Table 16. Global Pazopanib Sales Market Share by Company (2020-2022)
Table 17. Global Pazopanib Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Pazopanib Revenue Market Share by Company (2020-2022)
Table 19. Global Pazopanib Sale Price by Company (2020-2022) & (USD/Pcs)
Table 20. Key Manufacturers Pazopanib Producing Area Distribution and Sales Area
Table 21. Players Pazopanib Products Offered
Table 22. Pazopanib Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Pazopanib Sales by Geographic Region (2017-2022) & (K Pcs)
Table 26. Global Pazopanib Sales Market Share Geographic Region (2017-2022)
Table 27. Global Pazopanib Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Pazopanib Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Pazopanib Sales by Country/Region (2017-2022) & (K Pcs)
Table 30. Global Pazopanib Sales Market Share by Country/Region (2017-2022)
Table 31. Global Pazopanib Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Pazopanib Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Pazopanib Sales by Country (2017-2022) & (K Pcs)
Table 34. Americas Pazopanib Sales Market Share by Country (2017-2022)
Table 35. Americas Pazopanib Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Pazopanib Revenue Market Share by Country (2017-2022)
Table 37. Americas Pazopanib Sales by Type (2017-2022) & (K Pcs)
Table 38. Americas Pazopanib Sales Market Share by Type (2017-2022)
Table 39. Americas Pazopanib Sales by Application (2017-2022) & (K Pcs)
Table 40. Americas Pazopanib Sales Market Share by Application (2017-2022)
Table 41. APAC Pazopanib Sales by Region (2017-2022) & (K Pcs)
Table 42. APAC Pazopanib Sales Market Share by Region (2017-2022)
Table 43. APAC Pazopanib Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Pazopanib Revenue Market Share by Region (2017-2022)
Table 45. APAC Pazopanib Sales by Type (2017-2022) & (K Pcs)
Table 46. APAC Pazopanib Sales Market Share by Type (2017-2022)
Table 47. APAC Pazopanib Sales by Application (2017-2022) & (K Pcs)
Table 48. APAC Pazopanib Sales Market Share by Application (2017-2022)
Table 49. Europe Pazopanib Sales by Country (2017-2022) & (K Pcs)
Table 50. Europe Pazopanib Sales Market Share by Country (2017-2022)
Table 51. Europe Pazopanib Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Pazopanib Revenue Market Share by Country (2017-2022)
Table 53. Europe Pazopanib Sales by Type (2017-2022) & (K Pcs)
Table 54. Europe Pazopanib Sales Market Share by Type (2017-2022)
Table 55. Europe Pazopanib Sales by Application (2017-2022) & (K Pcs)
Table 56. Europe Pazopanib Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Pazopanib Sales by Country (2017-2022) & (K Pcs)
Table 58. Middle East & Africa Pazopanib Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Pazopanib Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Pazopanib Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Pazopanib Sales by Type (2017-2022) & (K Pcs)
Table 62. Middle East & Africa Pazopanib Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Pazopanib Sales by Application (2017-2022) & (K Pcs)
Table 64. Middle East & Africa Pazopanib Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Pazopanib
Table 66. Key Market Challenges & Risks of Pazopanib
Table 67. Key Industry Trends of Pazopanib
Table 68. Pazopanib Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Pazopanib Distributors List
Table 71. Pazopanib Customer List
Table 72. Global Pazopanib Sales Forecast by Region (2023-2028) & (K Pcs)
Table 73. Global Pazopanib Sales Market Forecast by Region
Table 74. Global Pazopanib Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Pazopanib Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Pazopanib Sales Forecast by Country (2023-2028) & (K Pcs)
Table 77. Americas Pazopanib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Pazopanib Sales Forecast by Region (2023-2028) & (K Pcs)
Table 79. APAC Pazopanib Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Pazopanib Sales Forecast by Country (2023-2028) & (K Pcs)
Table 81. Europe Pazopanib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Pazopanib Sales Forecast by Country (2023-2028) & (K Pcs)
Table 83. Middle East & Africa Pazopanib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Pazopanib Sales Forecast by Type (2023-2028) & (K Pcs)
Table 85. Global Pazopanib Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Pazopanib Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Pazopanib Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Pazopanib Sales Forecast by Application (2023-2028) & (K Pcs)
Table 89. Global Pazopanib Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Pazopanib Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Pazopanib Revenue Market Share Forecast by Application (2023-2028)
Table 92. Novartis Basic Information, Pazopanib Manufacturing Base, Sales Area and Its Competitors
Table 93. Novartis Pazopanib Product Offered
Table 94. Novartis Pazopanib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 95. Novartis Main Business
Table 96. Novartis Latest Developments
Table 97. GlaxoSmithKline Basic Information, Pazopanib Manufacturing Base, Sales Area and Its Competitors
Table 98. GlaxoSmithKline Pazopanib Product Offered
Table 99. GlaxoSmithKline Pazopanib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 100. GlaxoSmithKline Main Business
Table 101. GlaxoSmithKline Latest Developments
List of Figures
Figure 1. Picture of Pazopanib
Figure 2. Pazopanib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pazopanib Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Pazopanib Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Pazopanib Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 200mg Tables
Figure 10. Product Picture of 400mg Tables
Figure 11. Global Pazopanib Sales Market Share by Type in 2021
Figure 12. Global Pazopanib Revenue Market Share by Type (2017-2022)
Figure 13. Pazopanib Consumed in Renal Cell Carcinoma
Figure 14. Global Pazopanib Market: Renal Cell Carcinoma (2017-2022) & (K Pcs)
Figure 15. Pazopanib Consumed in Soft Tissue Sarcoma
Figure 16. Global Pazopanib Market: Soft Tissue Sarcoma (2017-2022) & (K Pcs)
Figure 17. Pazopanib Consumed in Other
Figure 18. Global Pazopanib Market: Other (2017-2022) & (K Pcs)
Figure 19. Global Pazopanib Sales Market Share by Application (2017-2022)
Figure 20. Global Pazopanib Revenue Market Share by Application in 2021
Figure 21. Pazopanib Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Pazopanib Revenue Market Share by Company in 2021
Figure 23. Global Pazopanib Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Pazopanib Revenue Market Share by Geographic Region in 2021
Figure 25. Global Pazopanib Sales Market Share by Region (2017-2022)
Figure 26. Global Pazopanib Revenue Market Share by Country/Region in 2021
Figure 27. Americas Pazopanib Sales 2017-2022 (K Pcs)
Figure 28. Americas Pazopanib Revenue 2017-2022 ($ Millions)
Figure 29. APAC Pazopanib Sales 2017-2022 (K Pcs)
Figure 30. APAC Pazopanib Revenue 2017-2022 ($ Millions)
Figure 31. Europe Pazopanib Sales 2017-2022 (K Pcs)
Figure 32. Europe Pazopanib Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Pazopanib Sales 2017-2022 (K Pcs)
Figure 34. Middle East & Africa Pazopanib Revenue 2017-2022 ($ Millions)
Figure 35. Americas Pazopanib Sales Market Share by Country in 2021
Figure 36. Americas Pazopanib Revenue Market Share by Country in 2021
Figure 37. United States Pazopanib Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Pazopanib Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Pazopanib Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Pazopanib Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Pazopanib Sales Market Share by Region in 2021
Figure 42. APAC Pazopanib Revenue Market Share by Regions in 2021
Figure 43. China Pazopanib Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Pazopanib Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Pazopanib Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Pazopanib Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Pazopanib Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Pazopanib Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Pazopanib Sales Market Share by Country in 2021
Figure 50. Europe Pazopanib Revenue Market Share by Country in 2021
Figure 51. Germany Pazopanib Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Pazopanib Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Pazopanib Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Pazopanib Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Pazopanib Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Pazopanib Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Pazopanib Revenue Market Share by Country in 2021
Figure 58. Egypt Pazopanib Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Pazopanib Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Pazopanib Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Pazopanib Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Pazopanib Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Pazopanib in 2021
Figure 64. Manufacturing Process Analysis of Pazopanib
Figure 65. Industry Chain Structure of Pazopanib
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
